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Abstract
Background: Approximately 5-10% of persons infected with M. tuberculosis develop tuberculosis, but the factors
associated with disease progression are incompletely understood. Both linkage and association studies have
identified human genetic variants associated with susceptibility to pulmonary tuberculosis, but few genetic studies
have evaluated extrapulmonary disease. Because extrapulmonary and pulmonary tuberculosis likely have different
underlying pathophysiology, identification of genetic mutations associated with extrapulmonary disease is
important.
Findings: We performed a pilot genome-wide association study among 24 persons with previous extrapulmonary
tuberculosis and well-characterized immune defects; 24 pulmonary tuberculosis patients and 57 patients with M.
tuberculosis infection served as controls. The Affymetrix GeneChip Human Mapping Xba Array was used for genotyping;
after careful quality control, genotypes at 44,175 single nucleotide polymorphisms (SNPs) were available for analysis.
Eigenstrat quantified population stratification within our sample; logistic regression, using results of the Eigenstrat
analysis as a covariate, identified significant associations between groups. Permutation testing controlled the family-wise
error rate for each comparison between groups. Four SNPs were significantly associated with extrapulmonary
tuberculosis compared to controls with M. tuberculosis infection; one (rs4893980) in the gene PDE11A, one (rs10488286)
in KCND2, and one (rs2026414) in PCDH15; one was in chromosome 7 but not associated with a known gene. Two
additional variants were significantly associated with extrapulmonary tuberculosis compared with pulmonary
tuberculosis; one (rs340708) in the gene FAM135B and one in chromosome 13 but not associated with a known gene.
The function of all four genes affects cell signaling and activity, including in the brain.
Conclusions: In this pilot study, we identified 6 novel variants not previously known to be associated with
extrapulmonary tuberculosis, including two SNPs more common in persons with extrapulmonary than pulmonary
tuberculosis. This provides some support for the hypothesis that the pathogenesis and genetic predisposition to
extrapulmonary tuberculosis differs from pulmonary tuberculosis. Further study of these novel SNPs, and more well-
powered genome-wide studies of extrapulmonary tuberculosis, is warranted.
Introduction
Although approximately one-third of the world’s popula-
tion is infected with M. tuberculosis, [1] only 5-10% of
infected individuals develop tuberculosis [2]. The primary
site of disease is usually the lungs, but extrapulmonary
sites may also be affected. Population-based surveys have
found that 20% of tuberculosis cases are extrapulmonary
[3]. With a global tuberculosis prevalence of 11.1 million
cases, [4] this suggests a global prevalence of extrapulmon-
ary tuberculosis of 2.2 million cases. Several factors are
known to be associated with disease progression, including
HIV infection, diabetes mellitus and malnutrition [5].
There is also evidence that some persons may have a
genetic predisposition to tuberculosis [6-12]. Both link-
age and association studies have identified candidate
genetic variants and regions of the genome associated with
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any medium, provided the original work is properly cited.tuberculosis risk [13-16], but they have focused primarily
on pulmonary disease. Because the pathophysiology of
pulmonary and extrapulmonary disease appears to differ
[17,18], and because extrapulmonary disease in particular
may be associated with an underlying immune defect
[19-21], it is important to assess for genetic variants speci-
fically associated with extrapulmonary tuberculosis.
Mutations in P2X7, [22] vitamin D receptor, [23] inter-
leukin (IL) 1 - b, [24] LTA,[25] IL-10 [25], and IL-10
together with IFN-g,[26-29] have been associated with
extrapulmonary disease in previous candidate gene stu-
dies, and support the hypothesis of a genetic predisposi-
tion to extrapulmonary tuberculosis. We have previously
confirmed the association between polymorphisms in the
genes for vitamin D receptor and IL 1 - b and extrapul-
monary disease, and reported a novel association between
a polymorphism in the Toll-like receptor 2 gene with
extrapulmonary tuberculosis, among black patients from
the United States [30]. In this previous study, a candidate
gene approach was utilized in which single nucleotide
polymorphisms (SNPs) previously associated with tuber-
c u l o s i sa sw e l la sS N P si nc a n d i d a t eg e n e si n v o l v e di n
tuberculosis pathogenesis were assessed. As a conse-
quence, that study had limited potential to uncover novel
genomic regions that play a role in the etiology of extra-
pulmonary tuberculosis. Rapid and affordable SNP geno-
typing across the entire genome is now possible, allowing
for genome mapping to uncover novel associations not
possible with a candidate gene approach. We are una-
ware of previous genome-wide association studies of
extrapulmonary tuberculosis. We have performed a pilot
genome-wide association study among HIV-seronegative
persons in which the immunologic defects associated
with extrapulmonary tuberculosis have been well-charac-
terized, including low unstimulated cytokine production
and low CD4+ lymphocyte levels [20,21,30].
Methods
Study participants
The study population was a pooled sample from two
previous immunologic studies and the inclusion criteria
for both studies have been described in detail previously
[20,21,30]. Patients were selected through the Nashville
Metropolitan Health Department Tuberculosis Clinic
and the Baltimore City Health Department Eastern
Chest Clinic, and all participants provided written
informed consent. Extrapulmonary disease was defined
as disease at any site outside of the pulmonary parench-
yma. Eligibility criteria for extrapulmonary tuberculosis
cases included: a history of completely treated culture-
confirmed extrapulmonary tuberculosis, age ≥ 18 years,
and HIV-seronegative status. Exclusion criteria for
extrapulmonary tuberculosis cases included serum crea-
tinine > 2 mg/dL, use of corticosteroids or other
immunosuppressive agents at the time of diagnosis or
time of study entry, malignancy, or diabetes mellitus.
The inclusion criteria for pulmonary tuberculosis con-
trols included a history of completely treated culture-
confirmed pulmonary tuberculosis, age ≥ 18 years, no
evidence of extrapulmonary tuberculosis, and HIV-sero-
negative status. Controls with latent M. tuberculosis
infection were at least 18 years old, HIV-seronegative,
and had a positive tuberculin skin test (purified protein
derivative positive (PPD +), defined as ≥ 10 mm indura-
tion after intradermal placement of 5 tuberculin units of
PPD) and without evidence of active tuberculosis. Parti-
cipants in this control group were U.S.-born (and there-
fore not vaccinated with BCG), and were mostly close
contacts of tuberculosis cases. The controls were
sampled from the same two clinic populations as the
cases, and were not related to the cases. Exclusion cri-
teria for both control groups were the same as for cases.
Laboratory Techniques
DNA was extracted from blood samples using the Pure-
gene DNA Isolation kit (Gentra Systems, Minneapolis,
MN) as per the manufacturer’s protocol. Genomic DNA
was stored at -70°C until genotyping. Laboratory person-
nel were blinded to the case-control status of the
specimens.
Genome-Wide DNA genotyping
All DNA samples underwent SNP genotyping using the
GeneChip
® Human Mapping 50 K Xba Array (Affyme-
trix, Inc., Santa Clara, CA). The manufacturer’s protocol
was followed for all procedures. Briefly, a complexity
reduction process was performed where genomic DNA
(250 ng) was digested with XbaI, ligated to XbaI adaptor
(Affymetrix), and amplified by polymerase chain reac-
tion (PCR) using primers specific to the ligated adaptor.
Cycling conditions were an initial denaturation of 94°C
for 3 minutes followed by 30 cycles of 94°C for 30 sec-
onds, 60°C for 45 seconds, and 68°C for 60 seconds. A
final extension of 68°C for 7 minutes concluded the
reactions. PCR products were assayed by gel electro-
phoresis, purified, fragmented to < 250 bp using dilute
DNaseI (Affymetrix), biotin end-labeled with terminal
deoxynucleotidyl transferase, and hybridized to the 50 K
Xba Array at 48°C for 16 hours at 60 rpm. The hybri-
dized arrays were washed and stained on Fluidics Sta-
tion 450 and scanned with the GeneChip Scanner
according to the manufacturer’s settings (Affymetrix).
The arrays were analyzed with software GDAS version
3.0.2 (Affymetrix), which provides rank scores for the
probability of particular genotypes at SNP loci. The
scores were AA or BB for homozygous alleles and AB
for heterozygous alleles, and confidence scores showed
the accuracy of the genotype call. Standard procedures
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samples were employed. An internal control run in par-
allel did not detect any DNA contamination. All proce-
dures were performed using the same lots of reagents.
Laboratory personnel were blinded to the case-control
status of the specimen.
Quality control
To prevent inclusion of genotyping errors in our asso-
ciation analysis, a 3-step filtering process was followed,
which included: 1) removal of SNPs with < 90% geno-
typing efficiency (such that less than 10% of data were
missing across all individuals in the dataset); 2) removal
of individuals with genotyping efficiency < 90% (such
that less than 10% of data were missing across all SNPs
for each individual; 3) removal of SNPs out of Hardy-
Weinberg equilibrium in PPD + controls (according to
the results of a Fisher’s Exact test) with p < 0.05 after
Bonferroni correction for the total number of SNPs
evaluated. PLINK version 1.04 [31] was used for quality
control analysis and data processing. Of the 58,494
SNPs genotyped on the chip, 13,946 SNPs were
removed for low genotyping rate (less than 90% of the
participants could be genotyped for those SNPs). Each
SNP was tested for deviation from Hardy-Weinberg
Equilibrium using Fisher’s exact tests in PPD + controls
only. SNPs with p < 0.05 (after a Bonferroni correction
for the number of tests performed) were removed (a
total of 373), leaving 44,175 SNPs for statistical analysis.
One PPD + control had < 90% genotyping efficiency
and was removed from the analysis, leaving 104 indivi-
duals from the original 105.
Statistical Analysis
The three patient groups (extrapulmonary tuberculosis,
pulmonary tuberculosis, PPD +) underwent three com-
parisons for analysis: 1) extrapulmonary tuberculosis vs.
PPD + controls to identify SNPs that are predictors of
extrapulmonary disease, 2) extrapulmonary vs. pulmon-
ary tuberculosis to identify differences between these
two forms of disease, and 3) both extrapulmonary + pul-
monary tuberculosis vs. PPD + controls to identify SNPs
associated with active tuberculosis in general.
Clinical and demographic characteristics were com-
pared among the three patient groups using the Krus-
kal-Wallis test for continuous variables and the chi-
squared or Fisher exact tests for categorical variables, as
appropriate based on distributional assumptions.
Population stratification, which refers to allele frequency
differences between cases and controls due to ancestry, is
an important concern in genetic association tests, as it can
cause spurious associations [32-34]. To address this pro-
blem in our diverse patient population the EIGENSTRAT
method, which uses principal component analysis (PCA),
was used to quantify and correct for population sub-struc-
ture and adjust for population stratification in association
analyses [35,36]. The EIGENSTRAT utility of the EIGEN-
SOFT package version 2.0 was used for our analysis [36].
The method infers axes of variation to reduce the dimen-
sionality of the data while describing as much variability as
possible. We used EIGENSTRAT to evaluate the top ten
Eigen vectors of the covariance matrix between the sam-
ples [36]. Figure 1 shows the first two axes of variation
from the PCA analysis. The results revealed two major
clusters within our population and a third small cluster
defined by a third axis of variation. These three groups (in
order) were consistent with the self-reported racial groups
of our sample (black, white, and Asian). These three clus-
ters were used as categorical covariates in the genetic asso-
ciation analysis.
PLINK version 1.04 [31] was used for association ana-
lyses. Logistic regression using the cluster definitions
from the EIGENSTRAT analysis as a covariate in each
regression model, was used to evaluate potential associa-
tions for each SNP, for each of the three comparisons
described above (using a genotypic encoding for the
SNP variables). Dummy encoding was used for each
SNP variable, such that no genetic model assumptions
were made in the analysis. WGA Viewer [37] was used
for the graphical representation of our data as well as
for the selection of the SNPs with the strongest evidence
for association. Annotation of SNPs was then done
using the Ensemble database release 59 [38].
A major concern in genetic association studies in gen-
eral, and genome-wide association studies in particular,
are false positive findings due to multiple comparisons
Figure 1 Population Sub-structure Within our Study Population
Using the Top Two Eigen Vectors Calculated by EIGENSTRAT.
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tions, at a nominal alpha rate of 0.05, 5% of the associa-
tions may be statistically significant by chance alone. To
decrease the false positive rate of the current study, per-
mutation testing of all 44,175 SNPs as a set [41] was used
to derive empirical cut-offs that corresponded to a family-
wise (experiment wise) error rate of 0.05 for each compari-
son. This less stringent empirical p-value was used instead
of the more widely used genome-wide significance thresh-
old of 5 × 10
-8 due to the small sample size of our study.
Permutation testing was implemented in PLINK, and
SNPs in each comparison with raw p-values below the
empirical p-value cut-off derived from permutation testing
corresponding to a family-wise error rate of 0.05 for each
of the three comparisons were considered statistically sig-
nificant. To check whether the association signals that
pass this significance threshold are due to linkage disequi-
librium (LD), r
2 scores for SNPs on the same chromosome
and/or gene were also calculated. The overall level of het-
erozygosity (Fst) in our sample was also calculated using
GENEPOP version 1.2 [42].
Results
There were 44,175 SNPs and 104 individuals for analysis
after applying our quality control filter: 24 extrapulmonary
tuberculosis cases, 24 pulmonary tuberculosis controls,
and 56 PPD + controls. The sites of extrapulmonary dis-
ease have been reported previously [30]; only 1 had central
nervous system (miliary/meningeal) disease. The clinical
and demographic characteristics of the 104 patients in the
study population are in Table 1. There were no statistically
significant differences by age, sex, or race between cases
and controls.
Figures 2, 3 and 4 show the distribution of SNPs and
the -log(p) values for each SNP from the logistic regres-
sion analysis for the three comparisons (extrapulmonary
tuberculosis vs PPD +, extrapulmonary tuberculosis vs
pulmonary tuberculosis and any tuberculosis vs PPD +,
respectively), as well as the coverage achieved using the
Affymetrix 50 k array. The empirical P-value cutoff
from permutation testing was 0.0009. Figures 5, 6 and 7
show Q-Q plots demonstrating the expected versus
observed -2log(p-values) for each comparison: extrapul-
monary tuberculosis vs PPD +, extrapulmonary tubercu-
losis vs pulmonary tuberculosis and any tuberculosis vs
PPD +, respectively. These Q-Q plots show the observed
versus expected p-values under the null hypothesis. A
large number of p-values above the diagonal line would
indicate strong signal within the data (especially at the
top right portion of the plot), whereas a large number
of p-values below the diagonal line indicate low statisti-
cal power. Deviation of the observed p-values from the
diagonal across the entirety of the plot (not just at the
top right) indicate possible technical concerns with the
study. Our results demonstrate that there are not major
technical concerns, but statistical power is low. Figure 6
demonstrates slight deviation from the diagonal, but
generally all comparisons show overall good quality.
T h e s ef i n d i n g ss h o u l db ek e p ti nm i n dw h e ni n t e r p r e t -
ing the results of this pilot study. The level of genetic
Table 1 Clinical and Demographic Characteristics of the
Study Population
Characteristic Extrapulmonary
TB (n = 24)
Pulmonary
TB (n = 24)
PPD +
(n = 56)
P-value
a
Median age at
study entry in
years (IQR)
48.4
(43.6-79.4)
43.6
(40.3-53.9)
46
(39.3-53.5)
0.19
# Male
Sex (%)
16 (67) 14 (58) 35 (63) 0.87
# Black
Race (%)
18 (75) 19 (79) 48 (86) 0.16
# White
Race (%)
4 (17) 4 (17) 8 (14) 0.27
# Asian
Race (%)
2 (9) 1 (4) 0 (0) 0.22
IQR: inter-quartile range.
Figure 2 Distribution of p-values from the Logistic Regression Test of Extrapulmonary Tuberculosis Cases vs. PPD + Controls.
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monary and extrapulmonary tuberculosis) and PPD +
controls was calculated using EIGENSTRAT [35] and
w a sf o u n dt ob e0 . 0 0 1 .T h i sd e m o n s t r a t e sal o wl e v e lo f
variability between those with prior tuberculosis disease
and the PPD + group, indicating little differentiation
among the groups, after accounting for racial differences.
Extrapulmonary tuberculosis vs. PPD + controls
There were four statistically significant SNPs between
these two patient groups, three of which are in known
genes: PDE11A, KCND2 and PCDH15 (Table 2). Two
of these SNPs (rs10487416 and rs10488286) were on the
same chromosome (chromosome 7) and the LD scores
for these two SNPs on chromosome 7 are in Table 3.
Extrapulmonary tuberculosis vs. pulmonary tuberculosis
There were two SNPs that were significantly different
between these two groups (Table 4), and the most sig-
nificant one (lowest p-value) was in the gene FAM135B.
The two SNPs were on different chromosomes so no
LD calculations were made for this subgroup.
Any tuberculosis vs. PPD + controls
Six SNPs were significantly different in this comparison
(Table 5), of which five (rs1989565, rs10490266,
rs2107005, rs509423, rs968079) were in known genes:
MARK3, AC007317.1, RP11-556L14.2, RP11-440N4
respectively, and SNP rs1518350 was not in any know
gene but was closest to the gene SLC35F1. Two SNPs
(rs2107005 and rs509423) were on the same chromosome
(chromosome 4), and their LD scores are in Table 3.
Discussion
The results of this pilot study reveal 6 SNPs that were sig-
nificantly associated with extrapulmonary tuberculosis:
four SNPs distinguished between extrapulmonary tubercu-
losis and M. tuberculosis infection and two distinguished
between extrapulmonary and pulmonary tuberculosis.
There were an additional 6 SNPs that distinguished
between active tuberculosis of any site (pulmonary or
extrapulmonary) and M. tuberculosis infection. None of
the SNPs identified have previously been reported to be
associated with tuberculosis. This is to be expected since
almost all of the SNPs included in the Affymetrix 50K Xba
Figure 3 Distribution of p-values from the Logistic Regression Test of Extrapulmonary Tuberculosis Cases vs. Pulmonary Tuberculosis
Controls.
Figure 4 Distribution of p-values from the Logistic Regression Test of all Tuberculosis Patients (Pulmonary and Extrapulmonary) vs.
PPD + Controls.
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with tuberculosis risk, nor in genes known to be important
in tuberculosis pathogenesis. Most of the SNPs were found
in regions with newly discovered genes of which very little
is known, as such, this study should be viewed as explora-
tory and a way to uncover potentially novel biology. The
SNPs identified should be evaluated in subsequent studies
of tuberculosis genetics, and their immunologic correlate
should be assessed.
The analysis of persons with extrapulmonary tuberculo-
sis vs. PPD + controls (Table 2) identified 4 SNPs that
were significantly associated with extrapulmonary disease.
Three of the SNPs were in known genes (PDE11A,
KCND2, PCDH15). While much is known about the func-
tion of these genes themselves, how they may potentially
play a role in tuberculosis pathogenesis is unclear. None of
these genes have previously been reported to be associated
with tuberculosis. PDE11A encodes a member of the PDE
superfamily, which plays a role in cAMP and cGMP func-
tion as second messengers in a wide variety of signal trans-
duction pathways. Mutations in this gene are a cause of
Cushing disease and adrenocortical hyperplasia [43]. The
gene also appears to play a significant role in regulating
brain function. KCND2 encodes a member of the family
of voltage-gated potassium channels (shal-related sub-
family) which is prominent in the repolarization phase of
the action potential [44]. The diverse functions of these
channels include regulating neurotransmitter release,
heart rate, insulin secretion, neuronal excitability, epithe-
lial electrolyte transport, smooth muscle contraction, and
cell volume. PCDH15 is a member of the cadherin super-
family. Family members encode integral membrane pro-
teins that mediate calcium-dependent cell-cell adhesion. It
plays an essential role in maintenance of normal retinal
and cochlear function. Mutations in this gene result in
hearing loss and Usher Syndrome Type IF [45].
It has been previously suggested that the pathogenesis
of pulmonary tuberculosis may differ from that of
Figure 5 Q-Q plot of the expected versus observed -2log(p-
values) for Extrapulmonary TB vs PPD +.
Figure 6 Q-Q plot of the expected versus observed -2log
(p-values) for Extrapulmonary TB vs Pulmonary TB.
Figure 7 Q-Q plot of the expected versus observed -2log(p-
values) for Any TB vs PPD +.
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under-powered to fully evaluate differences in genetic
predisposition, the results from the extrapulmonary
tuberculosis vs. pulmonary tuberculosis (Table 4) analysis
provides some evidence in support of this hypothesis.
Two SNPs were significantly associated with extrapul-
monary vs. pulmonary tuberculosis, one of which was in
a known gene FAM135B (family with sequence similar-
ity 135, member B). The gene FAM135B located on
chromosome 8 and is a protein coding gene that is
expressed in several tissues/organs such as the brain and
heart, but has not previously been linked to either form
of tuberculosis. The other significant polymorphism
(rs1886870) for this comparison is in a newly annotated
gene RP11-141M1 of which not much is currently
known.
The level of linkage disequilibrium between significant
S N P sf o u n do nt h es a m eg e n ea n dt h o s eo nt h es a m e
chromosome was calculated: the low correlation coeffi-
cient scores (r
2) suggest that the SNPs are independent
of each other (Table 3).
The biological relevance of the SNPs identified is diffi-
cult to determine because there is very little known
about these SNPs. Most were in unknown regions of the
genome and those that were found within gene regions
have not been associated with either extrapulmonary or
pulmonary tuberculosis. Additional study is warranted
to assess the possible biological relevance.
Our findings from the third comparison (both forms
of tuberculosis vs PPD + controls) identified 6 SNPs
associated with tuberculosis risk (Table 5). One of these
SNPs (rs1989565) was in the MARK3 (microtubule affi-
nity-regulating kinase 3) gene, which is a protein coding
gene that might play a role in the regulation of cell
polarity [46]. This gene has not previously been linked
with tuberculosis risk. Another SNP (rs968079) was
found to be in the gene PTPRD (protein-tyrosine phos-
phatase receptor-type delta) which has been associated
with asthma [47], Restless leg syndrome [48] and some
cancers as a tumor suppressor [49]. Three SNPs
(rs2107005, rs509423, rs10490266) were found in three
newly annotated genes and not much is known about
them. The final significant SNP in this comparison was
not found in any gene but was closest to the gene
SLC35F1(Solute Carrier Family 35, Member F1), which
is mainly expressed in the brain [50], but not much else
is known about its function.
Though our sample size was small we controlled for
population stratification to reduce the occurrence of
spurious results; such an approach has also been shown
to increase power [51]. Additionally, we used permuta-
tion testing to control for false positive findings. While
the current findings would not hold up to a stringent
Bonferroni correction for genome-wide significance, the
permutation testing does control the family-wise error
rate for these tests.
It is clear that the major limitation of this study was the
sample size, which leaves us under-powered to detect
small effects as shown by our Q-Q plots (Figures 5, 6 and
7), and therefore only very large effect sizes could be
detected. Although we did not have the power to detect
potentially important genetic predictors of tuberculosis
risk, the SNPs identified were by necessity, strong predic-
tors. They should also be interpreted within the context of
the immunologic deficits noted in these patients with pre-
vious extrapulmonary tuberculosis [20,21]. Our results
Table 2 Statistically Significant SNPs Identified in Extrapulmonary Tuberculosis Cases vs. PPD + Controls
SNP Rank P-value MAF in ETB MAF in PPD + Odds Ratio Chromosome Gene Closest Gene Distance to Gene
rs4893980 1 0.0007 0.1087 0.4902 0.1268 2 PDE11A ——
rs10487416 2 0.0007 0.25 0.0566 5.556 7 unknown unknown unknown
rs10488286 3 0.0009 0.2381 0.02727 11.15 7 KCND2 ——
rs2026414 4 0.0009 0.5208 0.2589 3.111 10 PCDH15 ——
Empirical P - value cutoff from permutation testing = 0.0009.
The p - value reported is the raw value.
MAF = Minor Allele Frequency.
ETB = Extrapulmonary tuberculosis.
PPD + = Purified protein derivative positive.
Table 3 Linkage Disequilibrium (LD) scores of Statistically Significant SNPs Identified in the Same Gene or
chromosome
chromosome Comparison SNP1 SNP2 D’ LOD r
2
7 ETB vs PPD + rs10487416 rs10488286 0.406 3.08 0.148
4 Any TB vs PPD + rs2107005 rs509423 0.345 0.95 0.043
PPD + = Purified protein derivative positive.
ETB = Extrapulmonary tuberculosis.
Any TB = Pulmonary or extrapulmonary tuberculosis.
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hypothesis testing, and should be evaluated in subsequent
studies of extrapulmonary tuberculosis with substantially
increased sample sizes.
A second limitation was the limited SNP coverage of
the Affymetrix 50 k array. In particular, large regions in
chromosomes 1, 9 and 16 were not covered. Newer
arrays, with a greater number of SNPs and more exten-
sive coverage, would potentially identify even more
novel SNP associations. However, the above issues of
sample size, statistical power, and multiple comparisons
would take on even greater importance.
Conclusions
Novel genetic factors were associated with susceptibility
to extrapulmonary tuberculosis, and these factors may
act through previously unknown pathophysiologic
mechanisms. The genes identified play a role in cellular
signaling, activity and polarity, with some appearing to
play an important role in the brain. Only one of the
patients with extrapulmonary disease had central ner-
vous system involvement. Future large-scale studies are
warranted in which persons with extrapulmonary tuber-
culosis and appropriate controls have both genetic and
immunologic features characterized. Additional studies
of the biologic function of the SNPs identified here
would also provide additional insight into the patho-
phyisology of extrapulmonary tuberculosis.
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